These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27931968)

  • 21. Borderline resectable pancreatic cancer: conceptual evolution and current approach to image-based classification.
    Gilbert JW; Wolpin B; Clancy T; Wang J; Mamon H; Shinagare AB; Jagannathan J; Rosenthal M
    Ann Oncol; 2017 Sep; 28(9):2067-2076. PubMed ID: 28407088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and Management of Borderline Resectable Pancreatic Adenocarcinoma.
    Schwarz L; Katz MH
    Hematol Oncol Clin North Am; 2015 Aug; 29(4):727-40. PubMed ID: 26226907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative FOLFIRINOX for borderline resectable pancreatic cancer: Is radiation necessary in the modern era of chemotherapy?
    Kim SS; Nakakura EK; Wang ZJ; Kim GE; Corvera CU; Harris HW; Kirkwood KS; Hirose R; Tempero MA; Ko AH
    J Surg Oncol; 2016 Oct; 114(5):587-596. PubMed ID: 27444658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current standards and new innovative approaches for treatment of pancreatic cancer.
    Conroy T; Bachet JB; Ayav A; Huguet F; Lambert A; Caramella C; Maréchal R; Van Laethem JL; Ducreux M
    Eur J Cancer; 2016 Apr; 57():10-22. PubMed ID: 26851397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Importance of resectability status in neoadjuvant treatment for pancreatic cancer.
    Sho M; Akahori T; Tanaka T; Kinoshita S; Nagai M; Tamamoto T; Ohbayashi C; Hasegawa M; Kichikawa K; Nakajima Y
    J Hepatobiliary Pancreat Sci; 2015 Jul; 22(7):563-70. PubMed ID: 25921623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative ultrasound ablation for borderline resectable pancreatic cancer: A report of 30 cases.
    Wang G; Zhou D
    Ultrason Sonochem; 2015 Nov; 27():694-702. PubMed ID: 26113389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Resection for advanced pancreatic cancer following multimodal therapy].
    Kleeff J; Stöß C; Yip V; Knoefel WT
    Chirurg; 2016 May; 87(5):406-12. PubMed ID: 27138271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS).
    Bockhorn M; Uzunoglu FG; Adham M; Imrie C; Milicevic M; Sandberg AA; Asbun HJ; Bassi C; Büchler M; Charnley RM; Conlon K; Cruz LF; Dervenis C; Fingerhutt A; Friess H; Gouma DJ; Hartwig W; Lillemoe KD; Montorsi M; Neoptolemos JP; Shrikhande SV; Takaori K; Traverso W; Vashist YK; Vollmer C; Yeo CJ; Izbicki JR;
    Surgery; 2014 Jun; 155(6):977-88. PubMed ID: 24856119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy.
    Christians KK; Heimler JW; George B; Ritch PS; Erickson BA; Johnston F; Tolat PP; Foley WD; Evans DB; Tsai S
    Surgery; 2016 Mar; 159(3):893-900. PubMed ID: 26602840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between surgical R0 resectability and findings of peripancreatic vascular invasion on CT imaging after neoadjuvant S-1 and concurrent radiotherapy in patients with borderline resectable pancreatic cancer.
    Yasuta S; Kobayashi T; Aizawa H; Takahashi S; Ikeda M; Konishi M; Kojima M; Kuno H; Uesaka K; Morinaga S; Miyamoto A; Toyama H; Takakura N; Sugimachi K; Takayama W
    BMC Cancer; 2020 Dec; 20(1):1184. PubMed ID: 33267820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival.
    Rose JB; Rocha FG; Alseidi A; Biehl T; Moonka R; Ryan JA; Lin B; Picozzi V; Helton S
    Ann Surg Oncol; 2014 May; 21(5):1530-7. PubMed ID: 24473642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "Shades of Gray" in pancreatic ductal adenocarcinoma: Reappraisals on resectability criteria: Debated indications for surgery in pancreatic cancer.
    Lombardi P; Silvestri S; Marino D; Santarelli M; Campra D; De Paolis P; Aglietta M; Leone F;
    Crit Rev Oncol Hematol; 2019 Jan; 133():17-24. PubMed ID: 30661653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Borderline resectable pancreatic cancer - a definition and effective treatment strategy].
    Yokoyama Y; Ebata T; Igami T; Sugawara G; Takahashi Y; Kokuryo T; Tsunoda N; Fukaya M; Uehara K; Itatsu K; Yoshioka Y; Nagino M
    Gan To Kagaku Ryoho; 2012 Mar; 39(3):337-41. PubMed ID: 22421757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How to treat borderline resectable pancreatic cancer: current challenges and future directions.
    Takahashi S
    Jpn J Clin Oncol; 2018 Mar; 48(3):205-213. PubMed ID: 29340601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detecting tumour response and predicting resectability after neoadjuvant therapy for borderline resectable and locally advanced pancreatic cancer.
    Barreto SG; Loveday B; Windsor JA; Pandanaboyana S
    ANZ J Surg; 2019 May; 89(5):481-487. PubMed ID: 30117669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New developments in the management of borderline resectable pancreatic cancer.
    Sharma J; Ng J; Goodman MD; Saif MW
    JOP; 2013 Mar; 14(2):123-5. PubMed ID: 23474551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of neoadjuvant therapy in patients 75 years of age and older with pancreatic cancer.
    Miura JT; Krepline AN; George B; Ritch PS; Erickson BA; Johnston FM; Oshima K; Christians KK; Evans DB; Tsai S
    Surgery; 2015 Dec; 158(6):1545-55. PubMed ID: 26243342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in Surgery and (Neo) Adjuvant Therapy in the Management of Pancreatic Cancer.
    Liu M; Wei AC
    Hematol Oncol Clin North Am; 2024 Jun; 38(3):629-642. PubMed ID: 38429197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How to define and manage borderline resectable pancreatic cancer.
    Papavasiliou P; Chun YS; Hoffman JP
    Surg Clin North Am; 2013 Jun; 93(3):663-74. PubMed ID: 23632151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Landmark Series: Neoadjuvant Treatment in Borderline Resectable Pancreatic Cancer.
    He J; Schulick RD; Del Chiaro M
    Ann Surg Oncol; 2021 Mar; 28(3):1514-1520. PubMed ID: 33415556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.